ホーム>>Lipids>> Prostaglandins>>11-deoxy-11-methylene Prostaglandin D2

11-deoxy-11-methylene Prostaglandin D2 (Synonyms: 11deoxy11methylene PGD2)

カタログ番号GC40335

プロスタグランジンD2は、PGH2から直接派生した5つの主要な酵素性プロスタグランジンの1つです。

Products are for research use only. Not for human use. We do not sell to patients.

11-deoxy-11-methylene Prostaglandin D2 化学構造

Cas No.: 100648-29-1

サイズ 価格 在庫数 個数
1mg
$98.00
在庫あり
5mg
$441.00
在庫あり
10mg
$782.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Prostaglandin D2 is one of the five primary enzymatic prostaglandins derived directly from PGH2 . PGD2 is produced abundantly in the CSF by the lipocalin-type PGD synthase, and in the periphery by myeloid cells including mast cells and basophils by a second, leukocyte-type PGD synthase. PGD2 is chemically unstable, and its use and analysis is complicated by its short in vivo half-life. 11-deoxy-11-methylene PGD2 is a novel, chemically stable, isosteric analog of PGD2 wherein the 11-keto group is replaced by an exocyclic methylene. In the PGE series, the analogous modification leads to a stable, somewhat less potent agonist which embodies the same uterine stimulant and cervical ripening activities as the parent prostaglandin. However, 11-deoxy-11-methylene PGD2 has been reported by one group to be essentially without agonist activity on human platelets, a DP1 receptor assay. The CRTH2-receptor actions of 11-deoxy-11-methylene PGD2 are not yet reported.

レビュー

Review for 11-deoxy-11-methylene Prostaglandin D2

Average Rating: 5 ★★★★★ (Based on Reviews and 23 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 11-deoxy-11-methylene Prostaglandin D2

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.